Loyal raises $27M, aims to give dog owners more time with their pets

Loyal is building an animal pharmaceutical company that is developing therapeutics aimed at extending both lifespan and healthspan for dogs.

Learn more about your ad choices. Visit podcastchoices.com/adchoices